Louisiana State Employees Retirement System Buys Shares of 7,500 Revvity, Inc. (NYSE:RVTY)

Louisiana State Employees Retirement System bought a new stake in shares of Revvity, Inc. (NYSE:RVTY) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 7,500 shares of the company’s stock, valued at approximately $820,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Gladius Capital Management LP increased its holdings in shares of Revvity by 84.1% in the 3rd quarter. Gladius Capital Management LP now owns 232 shares of the company’s stock valued at $26,000 after acquiring an additional 106 shares during the period. CENTRAL TRUST Co purchased a new position in shares of Revvity in the 4th quarter valued at $27,000. ORG Partners LLC purchased a new position in shares of Revvity in the 4th quarter valued at $32,000. JTC Employer Solutions Trustee Ltd purchased a new position in shares of Revvity in the 4th quarter valued at $33,000. Finally, Headinvest LLC purchased a new position in shares of Revvity in the 3rd quarter valued at $57,000. 86.65% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on the company. UBS Group downgraded Revvity from a “buy” rating to a “neutral” rating and lifted their price target for the company from $105.00 to $125.00 in a report on Tuesday, January 16th. Barclays boosted their target price on Revvity from $92.00 to $105.00 and gave the stock an “equal weight” rating in a research note on Thursday, January 25th. Stifel Nicolaus boosted their target price on Revvity from $95.00 to $110.00 and gave the stock a “hold” rating in a research note on Friday, February 2nd. KeyCorp boosted their target price on Revvity from $110.00 to $126.00 and gave the stock an “overweight” rating in a research note on Friday, February 2nd. Finally, Raymond James boosted their target price on Revvity from $106.00 to $127.00 and gave the stock an “outperform” rating in a research note on Friday, February 2nd. Six research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $118.91.

Insider Activity

In other news, insider Prahlad R. Singh sold 21,217 shares of the business’s stock in a transaction dated Monday, February 5th. The stock was sold at an average price of $104.28, for a total value of $2,212,508.76. Following the completion of the transaction, the insider now owns 92,801 shares of the company’s stock, valued at approximately $9,677,288.28. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 0.60% of the company’s stock.

Revvity Stock Down 0.6 %

Revvity stock opened at $101.51 on Friday. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.77 and a current ratio of 2.07. The business’s 50-day simple moving average is $104.66 and its two-hundred day simple moving average is $101.46. The company has a market cap of $12.54 billion, a PE ratio of 18.46, a PEG ratio of 2.67 and a beta of 1.09. Revvity, Inc. has a fifty-two week low of $79.50 and a fifty-two week high of $132.54.

Revvity (NYSE:RVTY) last posted its quarterly earnings results on Thursday, February 1st. The company reported $1.25 earnings per share for the quarter, beating the consensus estimate of $1.15 by $0.10. The business had revenue of $695.90 million for the quarter. Revvity had a return on equity of 7.41% and a net margin of 25.20%. Equities analysts anticipate that Revvity, Inc. will post 4.65 EPS for the current year.

Revvity Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 9th. Stockholders of record on Friday, July 19th will be issued a $0.07 dividend. This represents a $0.28 annualized dividend and a dividend yield of 0.28%. Revvity’s dividend payout ratio (DPR) is presently 5.09%.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.